<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="58647">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02342522</url>
  </required_header>
  <id_info>
    <org_study_id>CS/14/3/31002</org_study_id>
    <nct_id>NCT02342522</nct_id>
  </id_info>
  <brief_title>Effect of Remote Ischaemic Conditioning on Clinical Outcomes in STEMI Patients Undergoing PPCI</brief_title>
  <acronym>ERIC-PPCI</acronym>
  <official_title>Effect of Remote Ischaemic Conditioning on Clinical Outcomes in ST-segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention (ERIC-PPCI): A Multicentre Randomised Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University College, London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>British Heart Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>London School of Hygiene and Tropical Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>King's College London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oxford University Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University College, London</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether remote ischemic conditioning can reduce
      cardiac death and hospitalization for heart failure in patients presenting with a
      ST-elevation myocardial infarction and treated by percutaneous coronary intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ERIC-PPCI is a 2000 patient 30 UK site randomised controlled double-blind clinical trial
      which will investigate whether remote ischemic conditioning (RIC) can reduce cardiac death
      and hospitalization for heart failure at 12 months in patients presenting with a
      ST-elevation myocardial infarction (STEMI) and treated by percutaneous coronary intervention
      (PPCI). It also includes 2 sub-studies. The Biomarker sub-study will investigate the
      enzymatic infarct size at 6 months. The Cardiac Magnetic Resonance (CMR) sub-study will
      investigate infarct size at 6 months. This study is a research collaboration with Aarhus
      University in Denmark (CONDI2 trial ClinicalTrials.gov Identifier:NCT01857414).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rates of cardiac death and hospitalization for heart failure (HHF) at 1 year.</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rates of cardiac death and HHF at 30 days.</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rates of all-cause death, repeat coronary revascularisation, reinfarction, stroke at 30 days and 12 months.</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TIMI flow post-PPCI.</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life at 6-8 weeks and 12 months (EuroQol EQ-5D-5L).</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarkers substudy: Enzymatic infarct size - 48 hour area-under-the-curve (AUC) hsTrop T and CK-MB.</measure>
    <time_frame>1 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CMR substudy: Cardiac MRI in first week and at 6 months (primary endpoint infarct size at 6 mths).</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>STEMI</condition>
  <condition>Myocardial Reperfusion Injury</condition>
  <arm_group>
    <arm_group_label>Remote ischemic conditioning</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>On arrival at the hospital an AutoRIC device will be placed on the upper arm and an active RIC protocol will be delivered (4x5 min cycles of inflation to 220mmHg and deflation).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>On arrival at the hospital an AutoRIC device will be placed on the upper arm and a sham RIC protocol will be delivered (4x5 min cycles of simulated inflation and deflation).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Remote ischemic conditioning</intervention_name>
    <description>An automated autoRIC™ cuff will be placed on the upper arm and inflated to 200mmHg for 5 minutes and then deflated for 5 minutes, a cycle which will be undertaken 4 times in total. For patients presenting with a systolic blood pressure (SBP)≥175mmHg, a manual blood pressure cuff will be used and inflated to 25 mmHg above systolic blood pressure.</description>
    <arm_group_label>Remote ischemic conditioning</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham control</intervention_name>
    <description>An automated autoRIC™ cuff will be placed on the upper arm and a simulated inflation and deflation protocol will be applied.</description>
    <arm_group_label>Sham control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria

          1. Onset of STEMI symptoms within 12 hours, lasting for more than 30 minutes

          2. Patients older than 18 years

          3. Suspected STEMI (ST-elevation at the J-point in two contiguous leads with the cut-off
             points: ≥0.2 millivolt (mV) in men or ≥0.15 mV in women in leads V2-V3 and/or ≥0.1 mV
             in other leads)

          4. Eligibility for coronary angiography with follow on PPCI if indicated

        Exclusion criteria

          1. Previous coronary artery bypass graft surgery

          2. Myocardial infarction (MI) within the previous 30 days

          3. Treatment with thrombolysis within the previous 30 days

          4. Left bundle branch block (LBBB)

          5. Patients treated with therapeutic hypothermia

          6. Conditions precluding use of RIC (paresis of upper limb, use of an a-v shunt)

          7. Life expectancy of less than 1 year due to non-cardiac pathology
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Derek Hausenloy, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hatter Cardiovascular Institute, University College London</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Richard Evans</last_name>
    <phone>+44 207 927 2665</phone>
    <email>Richard.Evans@lshtm.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Manish Ramlall, BSc(Hons), MBChB</last_name>
    <phone>+44 203 447 9888</phone>
    <email>mrmanish45@yahoo.co.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>St Thomas Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon Redwood</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>John Radcliffe Hospital</name>
      <address>
        <city>Oxford</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rajesh Kharbanda</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <lastchanged_date>May 13, 2016</lastchanged_date>
  <firstreceived_date>October 20, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardioprotection</keyword>
  <keyword>STEMI</keyword>
  <keyword>PPCI</keyword>
  <keyword>Myocardial reperfusion injury</keyword>
  <keyword>Myocardial infarct size</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Reperfusion Injury</mesh_term>
    <mesh_term>Myocardial Reperfusion Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
